BUYINS.NET: ESLR, FFKT, GBTS, IDIX, OPTR, SNCR Have Also Been Added To Naked Short List Today
TMCnet - The World's Largest Communications and Technology Community
TMC Launches New Sites ::  NGC  |  4GWE  |  Green Tech  |  Satellite  |  IT |  ITEXPO  |  Healthcare  |  Smart Grid  |  M2M  |  Smart Products  |  AstriCon News  |  SATCON News
Share
TMCnews
[July 23, 2008]

BUYINS.NET: ESLR, FFKT, GBTS, IDIX, OPTR, SNCR Have Also Been Added To Naked Short List Today

(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:23072008

BUYINS.NET, www.buyins.net, announced today that these select companies
have been added to the NASDAQ, AMEX and NYSE naked short threshold
list: Evergreen Solar Inc. (NASDAQ: ESLR), Farmers Capital Bank Corp.
(NASDAQ: FFKT), Gateway Financial Holdings Inc. (NASDAQ: GBTS), Idenix
Pharmaceuticals Inc. (NASDAQ: IDIX), Optimer Pharmaceuticals Inc.
(NASDAQ: OPTR), Synchronoss Technologies Inc. (NASDAQ: SNCR). For a
complete list of companies on the naked short list please visit our web
site. To find the SqueezeTrigger Price before a short squeeze starts in
any stock, go to www.buyins.net.

Evergreen Solar Inc. (NASDAQ: ESLR) develops, manufactures, and markets
solar power products primarily in Europe and the United States. It
utilizes its proprietary ?String Ribbon' technology process in
manufacturing ribbons of crystalline silicon, which are then cut into
wafers. These wafers are the primary components of photovoltaic cells
that are used to produce solar panels. The company principally offers
solar wafer, a flat piece of crystalline silicon that can be processed
and assembled into a solar cell; solar cell, a device made from a
silicon wafer that converts sunlight into electricity; and solar panel,
an assembly of solar cells that are electrically interconnected and
laminated for electric power generation, such as on-grid and off-grid
generation. Evergreen sells its products through distributors, systems
integrators, and value-added resellers. It has a strategic partnership
with Q-Cells AG. The company was founded in 1994 and is headquartered
in Marlboro, Massachusetts. With 121.45 million shares outstanding and
28.33 million shares declared short as of July 2008, there is a failure
to deliver in shares of ESLR. According to quarterly data provided by
the SEC, there were still 14,830 shares of ESLR that were
failing-to-deliver as of September 28, 2007.

Farmers Capital Bank Corp. (NASDAQ: FFKT) a financial holding company,
offers banking and bank-related services to individuals, corporations,
and other customers in central and northern Kentucky. It accepts
various deposit products, such as non-interest bearing deposits,
savings accounts, time deposits, checking accounts, and term
certificate accounts. The company offers various lending products,
which include commercial, financial, and agricultural loans; real
estate loans, such as construction loans, residential loans, and loans
for farmland and other commercial enterprises; installment loans; and
personal loans and lines of credit. In addition, it provides cash
management services, safe deposit box rental, and funds transfer
services. Further, the company serves as an agent in providing credit
card loans; and operates as a trustee of personal trusts, executor of
estates, trustee for employee benefit trusts, and registrar, transfer
agent, and paying agent for bond issues. As of March 31, 2008, it had
36 banking locations in 23 communities throughout central and northern
Kentucky to individual, business, agriculture, government, and
educational customers. The company was founded in 1950 and is
headquartered in Frankfort, Kentucky. With 7.35 million shares
outstanding and 14,400 shares declared short as of July 2008, there is
a failure to deliver in shares of FFKT. According to quarterly data
provided by the SEC, there were still 13,156 shares of FFKT that were
failing-to-deliver as of August 17, 2007.

Gateway Financial Holdings Inc. (NASDAQ: GBTS) operates as the bank
holding company for Gateway Bank & Trust Co. that offers commercial and
retail banking services. It primarily engages in generating deposits
and originating loans. The company's deposit products include savings,
NOW, money market, and time accounts. Its lending portfolio comprises
short- to medium-term commercial and industrial, real estate,
agricultural, small business administration guaranteed, farmers home
administration guaranteed, mortgage, construction, personal loans, and
secured and unsecured loans. The bank also offers a range of products
and services, including Internet banking, direct deposit, travelers'
checks, safe deposit boxes, United States savings bonds, and automatic
account transfer services. In addition, it provides securities
brokerage, title insurance, and settlement services for real estate
transactions; property, casualty, life, and health insurance products
to businesses and individuals; and various mortgage products. As of
December 31, 2007, Gateway Financial Holdings operated 33 full-service
financial centers in Virginia and North Carolina. The company was
founded in 1998 and is headquartered in Raleigh, North Carolina. With
12.67 million shares outstanding and 411,300 shares declared short as
of July 2008, there is a failure to deliver in shares of GBTS.

Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) a biopharmaceutical company,
engages in the discovery and development of drugs for the treatment of
human viral and other infectious diseases in the United States and
Europe. It develops nucleoside/nucleotide polymerase inhibitors,
including IDX102 and IDX184, which are in late-stage preclinical
development; protease inhibitors; and non-nucleoside polymerase
inhibitors for the treatment of hepatitis C virus. The company also
develops IDX899 that has completed a phase I dose-escalation study for
the treatment of HIV-1 from the class of compounds known as
non-nucleoside reverse transcriptase inhibitors. In addition, Idenix
Pharmaceuticals holds licenses for Tyzeka and Sebivo products for the
treatment of patients with chronic hepatitis B. The company was founded
in 1998 and is headquartered in Cambridge, Massachusetts. Idenix
Pharmaceuticals, Inc. is a subsidiary of Novartis Pharma AG. With 56.34
million shares outstanding and 3.11 million shares declared short as of
July 2008, there is a failure to deliver in shares of IDIX. According
to quarterly data provided by the SEC, there were still 15,957 shares
of IDIX that were failing-to-deliver as of September 28, 2007.

Optimer Pharmaceuticals Inc. (NASDAQ: OPTR) a biopharmaceutical
company, focuses on discovering, developing, and commercializing
anti-infective products. The company develops products that treat
gastrointestinal infections and related diseases. Its two late-stage
anti-infective product candidates include OPT-80, an antibiotic in two
Phase III registration trials for the treatment of Clostridium
difficile-infections/Clostridium difficile-associated disease, the
common nosocomial diarrhea; and Prulifloxacin, an antibiotic in two
Phase III trials for the treatment of infectious diarrhea in travelers,
a community-acquired infection, which is caused by a range of bacteria.
It also develops OPT-1068/CEM-101, a pre-clinical antibiotic against
respiratory tract infections; an OPopS drug discovery platform;
OPT-822, a carbohydrate-based immunostimulant therapy for the treatment
of metastatic breast cancer that completed phase I trials; and OPT-88
as a disease-modifying intra-articular and as a therapy for
osteoarthritis. The company has a collaborative research and
development, and license agreement with Cempra Pharmaceuticals, Inc. to
discover, develop, and commercialize drugs based on macrolide and
ketolide compounds. Optimer Pharmaceuticals was founded 1998 and is
headquartered in San Diego, California. With 27.93 million shares
outstanding and 155,800 shares declared short as of July 2008, there is
a failure to deliver in shares of OPTR. According to quarterly data
provided by the SEC, there were still 64,675 shares of OPTR that were
failing-to-deliver as of September 12, 2007.

Synchronoss Technologies Inc. (NASDAQ: SNCR) provides multi-channel
transaction management solutions to the communications services and
digital content marketplaces primarily in North America. It offers
ActivationNow and ConvergenceNow platforms, which are hosted services
delivered over the Internet or a dedicated communication channel that
provides work flow management. The company's ActivationNow and
ConvergenceNow platforms comprise PerformancePartner Portal, a
graphical user interface that enables the entry of transaction data
into the gateway; Gateway Manager, which provides the capability to
fulfill multiple transactions; WorkFlow Manager that provides
interaction with third-party relationships, as well as enables
communications service providers (CSPs) to have a single transaction
view, including data from third-party systems; and Visibility Manager,
which offers a centralized reporting platform for intelligent analytics
around the workflow, transaction management information, historical


trending, and mobile reporting for users to receive critical
transaction data on mobile devices. Synchronoss Technologies offers its
products and services to wireless service providers, voice over
Internet protocol enablers, long distance carriers, and CSPs. The
company was founded in 2000 and is headquartered in Bridgewater, New
Jersey. With 32.75 million shares outstanding and 3.78 million shares
declared short as of July 2008, there is a failure to deliver in shares
of SNCR. According to quarterly data provided by the SEC, there were
still 13,591 shares of SNCR that were failing-to-deliver as of
September 27, 2007.

About BUYINS.NET



WWW.BUYINS.NET is a service designed to help bonafide shareholders of
publicly traded US companies fight naked short selling. Naked short
selling is the illegal act of short selling a stock when no affirmative
determination has been made to locate shares of the stock to
hypothecate in connection with the short sale. Buyins.net has built a
proprietary database that uses Threshold list feeds from NASDAQ, AMEX
and NYSE to generate detailed and useful information to combat the
naked short selling problem. For the first time, actual trade by trade
data is available to the public that shows the attempted size, actual
size, price and average value of short sales in stocks that have been
shorted and naked shorted. This information is valuable in determining
the precise point at which short sellers go out-of-the-money and start
losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and
publishes a proprietary SqueezeTrigger for each stock that has been
shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database
of nearly 2,050,000,000 short sale transactions goes back to January 1,
2005, and calculates the exact price at which the Total Short Interest
is short in each stock. This data was never before available prior to
January 1, 2005, because the Self Regulatory Organizations (primary
exchanges) guarded it aggressively. After the SEC passed Regulation
SHO, exchanges were forced to allow data processors like Buyins.net to
access the data.

The SqueezeTrigger database collects individual short trade data on
over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on
nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows
by approximately 50,000,000 short sale transactions and provides
investors with the knowledge necessary to time when to buy and sell
stocks with outstanding short positions. By tracking the size and price
of each month's short transactions, BUYINS.NET provides institutions,
traders, analysts, journalists and individual investors the exact price
point where short sellers start losing money.

All material herein was prepared by BUYINS.NET, based upon information
believed to be reliable. The information contained herein is not
guaranteed by BUYINS.NET to be accurate, and should not be considered
to be all-inclusive. The companies that are discussed in this opinion
have not approved the statements made in this opinion. This opinion
contains forward-looking statements that involve risks and
uncertainties. This material is for informational purposes only and
should not be construed as an offer or solicitation of an offer to buy
or sell securities. BUYINS.NET is not a licensed broker, broker dealer,
market maker, investment banker, investment advisor, analyst or
underwriter. Please consult a broker before purchasing or selling any
securities viewed on or mentioned herein. BUYINS.NET may receive
compensation in cash or shares from independent third parties or from
the companies mentioned.

BUYINS.NET affiliates, officers, directors and employees may also have
bought or may buy the shares discussed in this opinion and may profit
in the event those shares rise in value. Market commentary provided by
Thomas Ronk.

BUYINS.NET will not advise as to when it decides to sell and does not
and will not offer any opinion as to when others should sell; each
investor must make that decision based on his or her judgment of the
market.

This release contains "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section
21E the Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may", "future", "plan" or "planned", "will" or "should", "expected,"
"anticipates", "draft", "eventually" or "projected". You are cautioned
that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results
to differ materially from those projected in the forward-looking
statements, including the risks that actual results may differ
materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a companies'
annual report on Form 10-K or 10-KSB and other filings made by such
company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking
statements included herein, and not place undue reliance on such
statements. The forward-looking statements in this release are made as
of the date hereof and BUYINS.NET undertakes no obligation to update
such statements.

CONTACT: Thomas Ronk, CEO, BUYINS.NET
Tel: +1 800 715 9999
e-mail: Tom@buyins.net
WWW: http://www.buyins.net

((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).

Copyright ? 2008 M2 Communications Ltd.

[ Back To TMCnet.com's Homepage ]


Discussions:
Be the first to post a comment on this page!
 
By  
TMCnet
TMCnet Videos
Featured White Papers
Top Stories
Related VoIP News

Subscribe FREE to all of TMC's monthly magazines. Click here now.